Medigard, out of Queensland, Australia, has received FDA approval to market the company’s blood collection device in the US. Though the company has not officially named the product, we have some information to believe it will be called Vacugard BCD. In the meantime, Medigard is looking for manufacturing and distribution partners in America.
From the product page:
The Medigard blood collection sharps collector is a unique design using vacuum to capture the needle after blood collection has been completed. There are very few safety blood collection devices on the market and those that exist use a cumbersome and costly spring and other methods. The Medigard sharps collector has the potential to change forever the way blood is taken and aims to eliminate needlestick injury.
Single handed automatic retraction Full retraction of the needle into the plunger The needle is locked safely away and can be easily disposed of No blood aerosoling Allows for use of the standard blood collection and blood analysis tubes Operates as simply as existing products with enhanced hand control Simple design with a minimum number of parts making it easy and inexpensive to produce.